Zinzani, P. L., Mayer, J., Flowers, C., Bijou, F., Oliveira, A. C. D., Song, Y., Zhang, Q., Brociner, M., Bouabdallah, K., Ganly, P. S., Zhang, H., Yuen, S., Trneny, M., Auer, R., Huang, S., Shen, J., Hirata, J., Trotman, J. (2025). Final analysis of the randomized phase 2 ROSEWOOD study of zanubrutinib + obinutuzumab vs obinutuzumab monotherapy in patients with relapsed/refractory follicular lymphoma. Blood. https://doi.org/10.1182/blood-2025-227